Sera Prognostics Investor Relations Material
Latest events
Q1 2025
Sera Prognostics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sera Prognostics Inc
Access all reports
Sera Prognostics Inc. is a biotechnology company focused on developing diagnostic tests that predict pregnancy-related complications. The company uses proteomic technologies to identify biomarkers that assess the risk of conditions such as preterm birth and other adverse pregnancy outcomes. Sera Prognostics aims to provide healthcare providers with actionable information to improve maternal and neonatal health through early detection and intervention. The company is headquartered in Salt Lake City, Utah, and its shares are listed on the NASDAQ.
Key slides for Sera Prognostics Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Sera Prognostics Inc
R&D Day 2025
Sera Prognostics Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
SERA
Country
🇺🇸 United States